Novo Nordisk
NVO
#122
Rank
A$243.91 B
Marketcap
A$55.22
Share price
0.47%
Change (1 day)
-34.97%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report